Walleye Capital LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 35,000 shares of ARWR stock, worth $698,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,000
Previous 4,400
695.45%
Holding current value
$698,250
Previous $85,000
674.12%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
96.2MCall Options Held
388KPut Options Held
420K-
Black Rock Inc. New York, NY15.7MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$243 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$222 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$120 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$104 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.11B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...